Sodium Acetate Injection — Class II drug recall D-316-2013
Terminated recall by Hospira Inc., reported 2013-05-15, distributed nationwide. Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
| Recall number | D-316-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2013-02-26 |
| Classified | 2013-05-06 |
| Reported by FDA | 2013-05-15 |
| Terminated | 2014-11-10 |
| Distributed | Nationwide (US) |
| Quantity | 266,900 vials |
| Reason classes | sterility |
| NDC | 00409-7299, 00409-7299-73, 00409-7299-83 |
| Lot numbers | 11/14, 23-320-DK, 23-321-DK |
Product
Sodium Acetate Injection, USP, 40 mEq/20 ml (2 mEq/mL) 20 mL Single-Dose Fliptop, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-7299-73
Reason for recall
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-316-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.